Crossmark

Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking

Crossref DOI link: https://doi.org/10.1038/s12276-019-0223-5

Published Online: 2019-03-15

Published Print: 2019-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Murphy, Daniel E.

de Jong, Olivier G.

Brouwer, Maarten

Wood, Matthew J.

Lavieu, Grégory

Schiffelers, Raymond M.

Vader, Pieter
License Information

Text and Data Mining valid from 2019-03-01
More Information

Article History

Received: 28 November 2018

Accepted: 12 December 2018

First Online: 15 March 2019

Conflict of interest

: M.W. is a co-founder and nonexecutive director of Evox Therapeutics.